Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Chemoprevention of breast cancer: recommendations and rationale.

U.S. Preventive Services Task Force.

Ann Intern Med. 2002 Jul 2;137(1):56-8. No abstract available.

PMID:
12093249
2.

Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force.

Kinsinger LS, Harris R, Woolf SH, Sox HC, Lohr KN.

Ann Intern Med. 2002 Jul 2;137(1):59-69. Review.

PMID:
12093250
3.

Chemoprevention of breast cancer: recommendations and rationale.

[No authors listed]

Am Fam Physician. 2003 Mar 15;67(6):1309-14. Review. No abstract available.

4.

Chemoprevention of breast cancer.

Thomsen A, Kolesar JM.

Am J Health Syst Pharm. 2008 Dec 1;65(23):2221-8. doi: 10.2146/ajhp070663. Review.

PMID:
19020189
5.

Chemoprevention of breast cancer.

Zelnak AB, O'Regan RM.

Curr Probl Cancer. 2004 Jul-Aug;28(4):201-17. Review. No abstract available.

PMID:
15318323
6.

Chemoprevention of breast cancer.

Dalton RR, Kallab AM.

South Med J. 2001 Jan;94(1):7-15. Review.

PMID:
11213947
7.

Breast cancer chemoprevention: current clinical practice and future direction.

Bevers TB.

Biomed Pharmacother. 2001 Nov;55(9-10):559-64. Review.

PMID:
11769967
8.

The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials.

Martino S, Costantino J, McNabb M, Mershon J, Bryant K, Powles T, Secrest RJ.

Oncologist. 2004;9(2):116-25. Review.

9.

Raloxifene in breast cancer prevention.

Gennari L, Merlotti D, Paola VD, Nuti R.

Expert Opin Drug Saf. 2008 May;7(3):259-70. doi: 10.1517/14740338.7.3.259 . Review.

PMID:
18462184
10.

Tamoxifen, raloxifene and the prevention of breast cancer.

Bentrem DJ, Craig Jordan V.

Minerva Endocrinol. 2002 Jun;27(2):127-39. Review.

PMID:
11961504
11.
12.
13.

[Additional effect of SERM: mammary gland].

Kurebayashi J.

Clin Calcium. 2004 Oct;14(10):47-51. Review. Japanese.

PMID:
15577131
14.

Selective estrogen-receptor modulators for primary prevention of breast cancer.

Fabian CJ, Kimler BF.

J Clin Oncol. 2005 Mar 10;23(8):1644-55. Review. No abstract available.

PMID:
15755972
15.

[Breast cancer chemoprevention. Rational, trials results and future].

Cutuli B, Lesur A, Namer M, Kerbrat P.

Bull Cancer. 2009 May;96(5):519-30. doi: 10.1684/bdc.2009.0855. Review. French.

16.

The current status of breast cancer chemoprevention: a star is born.

Morrow M, Jordan VC.

J Surg Oncol. 2007 Jan 1;95(1):4-5. Review. No abstract available.

PMID:
17192883
17.

Breast cancer chemoprevention.

Rosenbaum Smith SM, Osborne MP.

Am J Surg. 2000 Oct;180(4):249-51. Review.

PMID:
11113429
18.

Chemoprevention of breast cancer: tamoxifen, raloxifene, and beyond.

Bao T, Prowell T, Stearns V.

Am J Ther. 2006 Jul-Aug;13(4):337-48. Review.

PMID:
16858170
19.

Chemoprevention of breast cancer.

O'Regan RM, Jordan VC.

Cancer Treat Res. 2001;106:137-54. Review. No abstract available.

PMID:
11225001
20.

Breast cancer prevention.

Rodabaugh KJ, Bloss JD.

Clin Obstet Gynecol. 2001 Sep;44(3):478-84. Review. No abstract available.

PMID:
11685873

Supplemental Content

Support Center